Stay updated on SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial

Sign up to get notified when there's something new on the SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now displayed, replacing the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:20:37.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Removed the funding-status banner from the study page; core trial details and navigation remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T06:46:12.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The updated page shows an updated enrollment figure and a refreshed last update timestamp, reflecting continued activity in the study record.
    Difference
    0.4%
    Check dated 2025-11-03T20:37:17.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Updated core content to reflect new operating-status notice and version 3.2.0; removed older version label v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T04:29:14.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes provided.
    Difference
    0.0%
    Check dated 2025-09-29T01:21:06.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T18:46:14.000Z thumbnail image

Stay in the know with updates to SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial page.